Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Medtronic
Express Scripts
Dow
Mallinckrodt

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

TECHNETIUM TC 99M SESTAMIBI Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Technetium Tc 99m Sestamibi, and what generic alternatives are available?

Technetium Tc 99m Sestamibi is a drug marketed by Cardinal Health 414, Jubilant Draximage, Mallinkrodt Nuclear, and Pharmalucence. and is included in four NDAs.

The generic ingredient in TECHNETIUM TC 99M SESTAMIBI is technetium tc-99m sestamibi kit. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the technetium tc-99m sestamibi kit profile page.

Summary for TECHNETIUM TC 99M SESTAMIBI
Drug patent expirations by year for TECHNETIUM TC 99M SESTAMIBI
Recent Clinical Trials for TECHNETIUM TC 99M SESTAMIBI

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 4
Mayo ClinicPhase 2
National Center for Research Resources (NCRR)Phase 2

See all TECHNETIUM TC 99M SESTAMIBI clinical trials

Pharmacology for TECHNETIUM TC 99M SESTAMIBI

US Patents and Regulatory Information for TECHNETIUM TC 99M SESTAMIBI

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cardinal Health 414 TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078809-001 Apr 28, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
Pharmalucence TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 079157-001 Jul 10, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
Jubilant Draximage TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078806-001 Apr 29, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
Mallinkrodt Nuclear TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078098-001 Sep 22, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Boehringer Ingelheim
Merck
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.